参考文献/References:
[1] Deandreis D, A1 Ghuzlan A, Auperin A, et al. Is (18) F-fluo-rodeoxyglueose-PET/CT useful for the presurgieal characterization of thyroid nodules with indeterminate fine needle aspiration eytolo-gy?. Thyroid, 2012, 22(2):165-172.
[2] Traugott AL, Dehdashti F, Trinkaus K, et al. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography:interim analysis. World J Surg, 2010, 34(6):1247-1253.
[3] de Geus-Oei LF, Pieters GF, Bonenkamp JJ, et al.18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med, 2006, 47(5):770-775.
[4] Hales NW, Krempl GA, Medina JE. Is there a role for fluo-rodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?. Am J Otolaryngol, 2008,29(2):113-118.
[5] Smith RB, Robinson RA, Hoffman HT, et al. Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid. Otolaryngol Head Neck Surg, 2008, 138(1):101-106.
[6] Kresnik E, Gallowitsch HJ, Mikoseh P, et al. Fluorine-18-fluo-rodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery, 2003, 133(3):294-299.
[7] Vriens D, de Wilt JH, van der Wilt GJ, et al. The role of [(18)F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy:Systematic review and meta-analysis of the literature. Cancer, 2011, 117(20):4582-4594.
[8] Shie P, Cardarelli R, Sprawls K, et al. Systematic review:preva-lence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun, 2009, 30(9):742-748.
[9] Ohba K, Nishizawa S, Matsushita A, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluo-rodeoxyglucose positron emission tomography in relatively young healthy subjects:results of 3-year follow-up. Endocr J, 2010, 57(5):395-401.
[10] Nilsson IL, Arnherg F, Zedenius J, et al. Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/com-puted tomography:practical management algorithm. World J Surg, 2011, 35(12):2691-2697.
[11] Wong C,Lin M,Chicco A,et al.The clinical sigiiificaiice and management of incidental focal FDG uplake in the thyroid gland on positron emission tomography/ciunputed tomography (PET/CT) in patients with non-thyroidal malignancy.Acta Radiol,2011,52(8):899-904.
[12] Ho TY,Liou MJ,Lin KJ,et al.Prevalence and significance of thyroid uptake detected by (18) F-FDG PET.Endocrine,2011,40(2):297-302.
[13] Bonabi S.Schmidt F,Broglie MA,et al.Thyroid incidentalomas inFDG-PET/CT:prevalence and clinical impact[J/OL].Eur ArchOtorhinolaryngol,2012[2012-02-10],http://www.springerlink.com/content/g330467522203587.[published online ahead of printFeb 2,2012
[14] Boec-kmann J,Bartel T,Siegel E,et al.Can the pathology of a thyroid nodule be determined by positron emission tomography uptake[J/OL]?.Otolaryngol Head Neck Surg,2012[2012-02-10].http://www.ncbi.nlm.nih.gov/puhmed/22307576.[published onlineahead of print tcb 3,2012]
[15] Bae JS,Chae BJ,Park WC,et al.Incidental thyroid lesions detected by FDO-PFT/CT:prevalence and risk of thyroid cancer.World J Surg Oncol,2009,7:63.
[16] Kang BJ,O JH,Baik JH,et al.Incidental thyroid uptake on F-18 FDG PET/CT:correlation with ulrrasonography and pathology.Ann Nucl Med,2009,23(8):729-737.
[17] Mitchell JC,Grant F,Evenson AR,et al.Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.Surgery,2005,138 (6):1166-1174.
[18] D’Souza MM,Marwaha RK,Sliarma R,el al.Prospective evaluation of solilary thyroid nodule on 18F-FDG PET/CT and high-resolution ullrasoiiography.Ann Nucl MED,2010,24(5):345-355.
[19] Zhai G,Zhang M,Xu H,et al.The role of 18F-flurodeoxyglucose positron emission tomography/computed tomography whole body imaging in the evaluation of focal thyroid incidentaloma.J Endocrinol Invest,2010,33(3):151-155.
[20] Jeong HS,Chung M,Baek CH,et al.Can[18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?.Laryngoscope,2006,116(12):2133-2137.
[21] Choi JW,Yoon YH,Kim SM,et al.Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial 18F-FDGPET/CT.Ann Surg Oncol,2011,18(5):1306-1311.
[22] Yun M,Noh TW,Cho A,et al.Visually discernible[18F] fluo-rodeoxygluco se uptake in papillary thyroid microcarcinoma:a potential new risk factor.J Clin Endocrinol Metab,2010,95(7):3182-3188.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[8]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[9]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[10]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]